{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:57:13Z","timestamp":1790773033168,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.purol.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T18:31:24Z","timestamp":1382380284000},"page":"1327-1341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Les m\u00e9dicaments antibiotiques en urologie"],"prefix":"10.1016","volume":"23","author":[{"given":"H.","family":"Chaussade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Coloby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2013.09.001_bib0005","series-title":"ONERBA rapport annuel","author":"ONERBA","year":"2011"},{"key":"10.1016\/j.purol.2013.09.001_bib0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.medmal.2010.03.002","article-title":"[Susceptibility to antibiotics of Escherichia coli isolated from community-acquired urinary tract infections]","volume":"40","author":"Fabre","year":"2013","journal-title":"Med Mal Infect"},{"issue":"10","key":"10.1016\/j.purol.2013.09.001_bib0015","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.purol.2013.03.009","article-title":"Analyse microbiologique de plus de 600\u00a0infections urinaires f\u00e9briles prises en charge dans un r\u00e9seau de soin","volume":"23","author":"Bruy\u00e8re","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2013.09.001_bib0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/j.1552-4604.1984.tb01818.x","article-title":"Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate","volume":"24","author":"Ferslew","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.purol.2013.09.001_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.purol.2013.09.001_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.clinthera.2005.07.001","volume":"27","author":"Ponte","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.purol.2013.09.001_bib0035","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1016\/j.fpurol.2010.04.002","article-title":"Infections urinaires et antibioth\u00e9rapie chez l\u2019insuffisant r\u00e9nal","volume":"20","author":"Sautenet","year":"2010","journal-title":"Prog Urol FMC"},{"key":"10.1016\/j.purol.2013.09.001_bib0040","series-title":"SELEXID (pivm\u00e9cillinam), antibiotique apparent\u00e9 aux b\u00eatalactamines. Avis de la commission de transparence 3\u00a0avril","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2013"},{"key":"10.1016\/j.purol.2013.09.001_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.purol.2008.10.022","article-title":"Traitement des infections urinaires non compliqu\u00e9es","volume":"19","author":"Bruyere","year":"2009","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2013.09.001_bib0110","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/jac\/dks222","article-title":"Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model","volume":"67","author":"Vellinga","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.purol.2013.09.001_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-007-7083-y","article-title":"Risk factors for community-acquired urinary tract infection due to quinolone-resistant E.\u00a0coli","volume":"36","author":"Colodner","year":"2008","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.purol.2013.09.001_bib0060","first-page":"E475","article-title":"Risk of acute kidney injury associated with the use of fluoroquinolones","volume":"185","author":"Bird","year":"2013","journal-title":"CMAL"},{"key":"10.1016\/j.purol.2013.09.001_bib0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.purol.2010.07.013","article-title":"Prostatite aigu\u00eb bact\u00e9rienne","volume":"20","author":"Bruyere","year":"2010","journal-title":"Prog Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2013.09.001_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1166-7087(08)70508-6","article-title":"Prostatite aigu\u00eb","volume":"18","author":"Bruyere","year":"2008","journal-title":"Prog Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2013.09.001_bib0075","first-page":"4","article-title":"Diagnostic, traitement et suivi des infections communautaires de l\u2019appareil urinaire de l\u2019homme et de la femme (cystite aigu\u00eb et py\u00e9lon\u00e9phrite aigu\u00eb) et de l\u2019appareil g\u00e9nital de l\u2019homme (prostatite aigu\u00eb)\u00a0: remarques g\u00e9n\u00e9rales","volume":"18","author":"Bruyere","year":"2008","journal-title":"Prog Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2013.09.001_bib0080","first-page":"9","article-title":"[Acute cystitis]","volume":"18","author":"Bruyere","year":"2008","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2013.09.001_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing Escherichia coli infections","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.purol.2013.09.001_bib0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4212\/cjhp.v64i4.1039","article-title":"Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient","volume":"64","author":"Kiang","year":"2011","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.purol.2013.09.001_bib0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(17)63069-6","article-title":"Antibacterial concentrations in prostatic fluid. 1. Nitrofurantoin","volume":"97","author":"Dunn","year":"1967","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.09.001_bib0100","series-title":"Mise au point sur le bon usage des aminosides administr\u00e9s par voie injectable\u00a0: gentamicine, tobramycine, n\u00e9tilmicine, amikacine. Propri\u00e9t\u00e9s pharmacologiques, indications, posologies et modes d\u2019administration, surveillance du traitement","author":"AFSSAPS","year":"2011"},{"key":"10.1016\/j.purol.2013.09.001_bib0105","first-page":"490","article-title":"[Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP]","volume":"12","author":"Wang","year":"2006","journal-title":"Zhonghua Nan Ke Xue"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713006672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713006672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:24:15Z","timestamp":1761114255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708713006672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":21,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1166708713006672"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2013.09.001","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les m\u00e9dicaments antibiotiques en urologie","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}